Evidence map›Paper›PMID 30127433›Full record

ArticleNature immunology2018

Control of inducible gene expression links cohesin to hematopoietic progenitor self-renewal and differentiation.

Sergi Cuartero, Felix D Weiss, Gopuraja Dharmalingam, Ya Guo, Elizabeth Ing-Simmons, Silvia Masella, Irene Robles-Rebollo, Xiaolin Xiao, Yi-Fang Wang, Iros Barozzi and 12 more

Abstract read
In one paragraph

Article in Nature immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 159 papers.

0numbers the graph read from it
0cells of the map it votes in
159citing papers in PubMed
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

159 citing papers in PubMed, 236 citations in OpenAlex.

  1. Regulation of immune signal integration and memory by inflammation-induced chromosome conformation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Epigenetic regulation and chromatin organization in cystic fibrosis airways.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Frontiers in immunology · 2026
    Article
  20. Article

99 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 8 countries.

Sergi CuarteroLymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Felix D WeissLymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Gopuraja DharmalingamMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Ya GuoLymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Elizabeth Ing-SimmonsLymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-0394-2429
Silvia MasellaDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Irene Robles-RebolloLymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Xiaolin XiaoMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Yi-Fang WangMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Iros BarozziDepartment of Experimental Oncology, European Institute of Oncology, Milan, Italy.
Dounia DjeghloulLymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Mariane T AmanoLymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Henri NiskanenA. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Enrico PetrettoMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Robin D DowellBioFrontiers Institute and Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO, USA.
Kikuë TachibanaDepartment of Biochemistry, University of Oxford, Oxford, UK.
Minna U KaikkonenA. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.ORCID http://orcid.org/0000-0001-6294-0979
Kim A NasmythDepartment of Biochemistry, University of Oxford, Oxford, UK.
Boris LenhardComputational Regulatory Genomics Group, Integrative Biology Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Gioacchino NatoliHumanitas Clinical and Research Center, Milan, Italy.
Amanda G FisherLymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Matthias MerkenschlagerLymphocyte Development Group, Epigenetics Section, MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK. matthias.merkenschlager@lms.mrc.ac.uk.ORCID http://orcid.org/0000-0003-2889-3288
MRC London Institute of Medical Sciences · GBUniversity of Eastern Finland · FIDuke-NUS Medical School · SGEuropean Institute of Oncology · ITHospital Sírio-Libanês · BRHumanitas University · ITImperial College London · GBInstitute of Molecular Biotechnology · ATMax Planck Institute for Molecular Biomedicine · DEUniversity of Colorado Boulder · USUniversity of Oxford · GB

Funding

Cancer Research UK 12386Cancer Research UK 26747European Research Council 692789Medical Research Council MC_EX_MR/S300009/1Medical Research Council MC_U120027516Medical Research Council MC_UP_1102/1Wellcome Trust 078241Wellcome Trust 099276
6 · The paper itself

Abstract

Cohesin is important for 3D genome organization. Nevertheless, even the complete removal of cohesin has surprisingly little impact on steady-state gene transcription and enhancer activity. Here we show that cohesin is required for the core transcriptional response of primary macrophages to microbial signals, and for inducible enhancer activity that underpins inflammatory gene expression. Consistent with a role for inflammatory signals in promoting myeloid differentiation of hematopoietic stem and progenitor cells (HPSCs), cohesin mutations in HSPCs led to reduced inflammatory gene expression and increased resistance to differentiation-inducing inflammatory stimuli. These findings uncover an unexpected dependence of inducible gene expression on cohesin, link cohesin with myeloid differentiation, and may help explain the prevalence of cohesin mutations in human acute myeloid leukemia.

Indexed as

AnimalsCell Cycle ProteinsCell DifferentiationCells, CulturedCell Self RenewalChromosomal Proteins, Non-HistoneCohesinsDNA-Binding ProteinsGene Expression RegulationHematopoietic Stem CellsHigh-Throughput Nucleotide SequencingHumansInflammationLeukemia, Myeloid, AcuteLipopolysaccharidesMacrophagesCell Cycle ProteinsChromosomal Proteins, Non-HistoneCohesinsDNA-Binding ProteinsLipopolysaccharidesNuclear ProteinsPhosphoproteinsRad21 protein, mouse

Identifiers

PMID30127433
PMCPMC6195188
OpenAlexW2886894187

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.